Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.